Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Research & Studies
Share your love
Study shows significant ocular changes following hemodialysis | Ophthalmology Times
(Image Credit: AdobeStock/Kiryl Lis) A new study from Poland found that one session of hemodialysis caused changes in the anterior and posterior segments of the eye.1 The investigators, led by Joanna Roskal-Wałek, MD, published their results in the Journal of…
FDA grants Fast Track Designation to Complement Therapeutics’ CTx001 for geographic atrophy | Ophthalmology Times
(Image Credit: AdobeStock/Tada Images) The US Food and Drug Administration (FDA) has granted Fast Track Designation to Complement Therapeutics’ CTx001, the company’s lead gene therapy candidate for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD). The…
First patient treated in dose-expansion portion of SpliceBio’s phase 1/2 ASTRA clinical trial | Ophthalmology Times
(Image Credit: AdobeStock/Ilya) SpliceBio has dosed the first patient in the Part B dose-expansion portion of its phase 1/2 ASTRA clinical trial (NCT06942572) evaluating SB-007 for the treatment of Stargardt disease. SB-007 is an investigational dual adeno-associated virus (AAV) gene…
Glaucoma innovation: Eight themes to watch in 2026 | Ophthalmology Times
Glaucoma care is evolving through the integration of artificial intelligence, advanced procedures, and personalized treatment strategies. (Image credit: AdobeStock/thodonal) As the ophthalmology community observes Glaucoma Awareness Month this January, glaucoma specialists point to incremental integration of technologies that support earlier…
New optoretinography technique allows direct measurement of rod function in vivo | Ophthalmology Times
(Image Credit: AdobeStock/neosiam) A press release from the University of Washington, Seattle, reported what they described as a future diagnostic tool to view how the ocular molecules work. “Researchers have validated an approach to measure how rod photoreceptors, the cells…
iOpeners with Nicole Bajic, MD: Mary Qiu, MD, on tailored NVG pathways | Ophthalmology Times
With January being Glaucoma Awareness Month, it seems fitting to discuss neovascular glaucoma (NVG), a challenging and vision-threatening condition that requires thoughtful, individualized management. In this episode of iOpeners from Ophthalmology Times, host Nicole Bajic, MD, comprehensive ophthalmologist at the…
FDA update: Outlook Therapeutics receives CRL for resubmitted ONS-5010 BLA | Ophthalmology Times
Outlook Therapeutics, Inc. reported that the FDA has issued a complete response letter (CRL) concerning the resubmitted biologics license application (BLA) for ONS-5010/LYTENAVA (bevacizumab-vikg).1,2 The letter noted that the agency cannot approve the application in its current form for the…
Inside the clinic: Surgeon shares real-world experience | Ophthalmology Times
(Image Credit: AdobeStock) One of the most striking results with the Light Adjustable Lens (LAL; RxSight) is how quickly patients achieve excellent vision. With traditional IOLs, vision is expected to stabilize gradually over several days as the eye heals. With…
What changed in glaucoma care in 2025: Surgeon perspective | Ophthalmology Times
In a year-end conversation, Oluwatosin U. Smith, MD, of Glaucoma Associates of Texas, in Dallas, sat down with the Eye Care Network to reflect on how glaucoma care evolved as 2025 drew to a close. Framing the discussion as a…
Global trial equity: How LMIC data is reshaping US ophthalmology research | Ophthalmology Times
Incorporating data from low- and middle-income countries may help redefine how ophthalmology trials are designed, evaluated, and applied in practice (Image credit: AdobeStock/PUTRABATARA) Innovation in ophthalmology is often measured by what reaches the clinic—but the path to those breakthroughs begins…